The European Commission has signed a new agreement for the joint procurement of influenza vaccines. The 17 member states will have the opportunity to purchase more than 27 million doses of Foclivia from Seqirus UK Ltd.
Flu vaccine for 17 countries: a joint EU order
Published April 30, 2025 07:36
Fot. Getty Images/iStockphoto
The European Union is strengthening its preparedness for a pandemic influenza outbreak. The European Commission, through the Health Emergency Preparedness and Response Authority (HERA), has signed a new agreement with Seqirus UK Ltd. for the joint procurement of vaccines. The agreement includes the possibility for 17 countries to purchase up to 27,403,200 doses of Foclivia vaccine.
The Foclivia vaccine was developed as a means of protecting against pandemic influenza - a situation in which a new, easily transmitted strain of the virus spreads among people against which the public has no immunity. Such a scenario could be declared by the World Health Organization (WHO) or the European Union.
The framework agreement is for 48 months, with the possibility of two 12-month extensions, and follows on from previous agreements - with CSL Seqirus in 2019 and GSK in 2022 - which also secured access to pandemic vaccines.
The experience of the COVID-19 pandemic has shown the importance of a rapid and coordinated response to cross-border health threats.
Joint procurement is carried out through a voluntary EU mechanism that currently covers 38 countries - all EU countries and the European Economic Area. The mechanism allows participating countries to jointly procure medical countermeasures such as vaccines, therapies or medical devices. The main goal is to increase availability, security of supply and better prepare for future health threats.
Source: EC
